Skip to main content
. Author manuscript; available in PMC: 2025 Jul 24.
Published in final edited form as: Transpl Infect Dis. 2025 Jul 8;27(5):e70077. doi: 10.1111/tid.70077

TABLE 2 ∣.

Invasive fungal disease incidencea among solid organ transplant and hematopoietic cell transplant recipients, by region, United States, 2018–2022.

Infection type Solid organ Hematopoietic cell


Midwest Northeast South West Missing Midwest Northeast South West Missing
Mold 8.9 11.2 4.8 5.6 16.8 6.4 8.8 4.6 11.4 6.2
 Aspergillosis 8.7 10.8 4.5 5.6 14.7 6.0 6.1 3.6 9.4 6.2
 Mucormycosis 0.3 0.9 0.4 0.0 2.1 0.4 2.7 1.0 2.7 0.0
Candidiasis 3.1 1.3 2.9 3.0 6.3 2.8 2.7 3.4 3.4 6.2
Endemic 3.3 1.7 1.9 9.0 6.3 0.7 0.7 1.7 1.3 0.0
 Blastomycosis 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0
 Coccidioidomycosis 0.0 0.4 0.2 8.1 2.1 0.4 0.0 0.5 1.3 0.0
 Histoplasmosis 3.1 1.3 1.5 0.9 4.2 0.4 0.7 1.0 0.0 0.0
Cryptococcosis 1.8 0.4 1.9 1.3 2.1 0.0 0.7 0.0 0.0 0.0
Pneumocystosis 2.0 2.6 1.7 1.3 2.1 5.0 10.9 8.2 6.7 12.3
Unspecified 3.3 6.9 4.1 1.3 4.2 5.3 10.9 10.2 5.4 12.3
a

Incidence displayed as the number of patients with IFD (incidence per 1000 person-years). Patients could have been diagnosed with more than one IFD type on the same day. Region refers to the US census region of primary beneficiary’s residence. Map of US census regions: https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf.